MINISTRY OF EDUCATION AND TRAINING MINISTRY OF DEFENCE 108 INSTITUTE OF CLINICAL MEDICAL AND PHARMACEUTICAL SCIENCES NGUYEN DUNG LATE POTENTIALS CHARACTERISTICS AND VENTRICULAR ARRHYTHMIAS IN CHRONIC[.]
Trang 1MINISTRY OF EDUCATION AND TRAINING MINISTRY OF DEFENCE
108 INSTITUTE OF CLINICAL MEDICAL AND PHARMACEUTICAL SCIENCES
-
NGUYEN DUNG
LATE POTENTIALS CHARACTERISTICS AND
VENTRICULAR ARRHYTHMIAS IN CHRONIC ISCHEMIC
HEART DISEASE PATIENTS
Majors/Speciality: Internal medicine/Internal cardiology
Code: 9720107
SUMMARY OF MEDICAL PhD THESIS
Hanoi – 2023
Trang 2The thesis was done at:
108 Institute of Clinical Medical and Pharmaceutical sciences
Supervisors:
1 Assoc Prof PhD Pham Thai Giang
2 Assoc Prof PhD Pham Nguyen Son
Reviewers:
1
2
3
This thesis will be presented at the Institute Council at:
108 Institute of Clinical Medical and Pharmaceutical sciences
Day Month Year 20
This thesis can be found at:
1 National Library of Vietnam
2 Library of 108 Institute of Clinical Medical and Pharmaceutical sciences
Trang 3INTRODUCTION
1 Necessity of the thesis
Chronic ischemic heart disease (IHD) or stable coronary artery disease (CAD) and chronic coronary artery syndrom as Consensus of the European Society of Cardiology 2019 This disease affected about 126 million individuals (1,655/100,000), about 1.72% of the world population, of which about 9 million deaths caused by: arrhythmia, heart failure, or heart attack Arrhythmias, especially ventricular arrhythmias, including ventricular tachycardia, ventricular fibrillation, can cause cardiac arrest, even sudden death
Stratification and risk prediction for ventricular arrhythmias in patients with chronic IHD was important, and late potentials could help predict dangerous arrhythmias and predict cardiovascular disease There were many studies on late potential, but no study on late potential and its association with ventricular arrhythmias in patients with chronic IHD
2 Meaning of the study
The assessment, prediction, and risk stratification would help prevent and treat effectively Late ventricular potential recording was an effective, inexpensive, noninvasive, bedside technique that contributes to risk stratification for dangerous ventricular arrhythmias in patients with chronic IHD
3 Objectives of the study
1 To investigate of clinical, subclinical and late potential characteristics
in patients with chronic IHD
2 To assess the relationship between late potential and clinical characteristics, subclinical and ventricular arrhythmias in patients with chronic IHD
4 The layout of the thesis
The thesis had 125 pages, including: introduction and study objectives (2
pages), overview (35 pages), research objects and methods (19 pages), research
results (28 pages), discussion (36 pages), conclusion (2 pages) and recommendations (1 page) The thesis had 50 tables, 3 charts, 12 images, 170
references, 17 of which were Vietnamese and 153 English
Trang 4CHAPTER 1: OVEVIEW
Chronic IHD, also known as chronic CAD, was a condition that occured when blood flow to the heart was reduced, usually dued to a partial or completed blockage of the coronary arteries that feed the heart, reducing the heart's ability
to pump, leading to heart failure, to heart attacks or serious arrhythmias
1.1 Causes
- Atherosclerosis: Atherosclerotic plaque accumulated on the thickened coronary artery wall, narrowing the coronary artery, obstructing blood flow, this was the most common cause
- Blood clots: Atherosclerotic plaques could rupture causing blood clots, blocking the coronary arteries leading to myocardial ischemia Sometimes blood clots traveled from somewhere else
- Coronary artery spasm: Prinzmetal's syndrome
- Other causes: exertion, emotional stress, cold, stimulant abuse, overeating, violent sex
1.2 Symptoms
1.2.1 Symptoms
- Angina: the most important clinical symptom The pain was usually behind the sternum and was an area (not a point), could spread to the neck, shoulder, hand, jaw, epigastric, back, commonly opened out to the left shoulder, then spread to the inner surface of the left hand, sometimes down to the fingers
4, 5 It occured while exertion, strong emotions, cold, after a lot of meals or smoking and quickly decreased/ disappeared within a few minutes when the above factors decreased
- Dyspnea: In patients with high risk of CAD, dyspnea was an important clinical indicator and was recommended by the ESC 2019 in addition to angina
of ischemic arrhythmias
Trang 5- Assess the prior probability and the likelihood of disease
- Select the appropriate diagnostic exploration method
1.5 Complications of chronic IHD
- Myocardial infarction (MI): A coronary artery was completely blocked
leading to MI, which was one of the serious complications, which could be fatal
- Heart failure: Over time, IHD could lead to heart failure
- Arrhythmias: Abnormal heart rhythms could disrupt the heart's
contractile activity, which could be life-threatening Includes: tachyarrhythmias (ventricular tachycardia, ventricular fibrillation) and bradyarrhythmias (sick sinus syndrome )
Mechanism of arrhythmia in patients with chronic IHD
Ischemia caused electrophysiological changes in myocardial cells, dispersed the repolarization and refraction time between the ischemic and healthy myocardium, changed electricity in ischemic hypertrophic myocardium, as well as after repolarization refraction, decreased conduction velocity At the same time there was an extracellular accumulation of potassium, the action of the sodium - potassium pump was incompletely inhibited in the ischemic myocardium, reducing the ability to maintain the potassium concentration difference The process of ischemia changed cell membrane permeability, changed the entry and exit mechanism of ions, changed intracellular Ca++, increased extracellular K+, decreased intracellular and extracellular pH, increased Ca++ and Na+ influx Accumulation of lysophospholipids inhibited some ion channels, causing changes in action potentials, causing cardiac arrhythmias In addition,
Trang 64myocardial ischemia also increased catecholamine release, adrenorecepter activation leading to an increased risk of ventricular arrhythmias
1.6 Late potential and signal averaged electrocardiogram (SAECG)
Late potential was considered to be the body surface expression of late conduction in the heart, caused by ischemic or damaged myocardial areas, in patients with chronic ischemic heart disease or chronic heart failure In many studies, it had been found that there was a high rate of coronary artery disease in patients with dangerous ventricular arrhythmias Therefore, late potential was a prognostic indicator of patients at high risk of developing dangerous ventricular arrhythmias such as ventricular tachycardia, ventricular fibrillation in patients with chronic ischemic heart disease
Ventricular late potentials are high-frequency, low-amplitude waves (1 to
40 µV), occurring in the terminal part of the QRS complex, recorded by a signal averaging and amplifying electrocardiogram (SAECG) Late potential parameters include:
+ HFQRS: The QRS duration based on the filtered high frequency signal
+ LAHF: Duration of the high frequency, low amplitude portion at the end
CHAPTER 2: RESEARCH OBJECTS AND METHODS
2.1 Objects
Selection criterias
Selection criterias for patients
162 old MI patients with or without revascularization, or patients had coronary angiography with stenosis greater than 50% of the diameter of the coronary artery
Selection criterias for control group
87 people with no history and/or no cardiovascular disease or conditions affecting the heart: physical examination, 12-lead ECG at rest, routine echocardiography showed normal results
Trang 7 Exclusion criterias
Who need of immediate treatment: acute coronary syndrome, persistent ventricular tachycardia, ventricular fibrillation, high-grade atrioventricular block, severe electrolyte disturbances… Who was taking drugs that affect the heart rhythm a lot, such as: Digoxin, Atropin, Amidarone but could not be stopped Who had results
of SAECG and Holter were too noisy, the time of wearing the Holter electrocardiogram machine was less than 22 hours Not agreeing to participate in the study
2.2 Methods
Methods: Cross-sectional, descriptive, controlled study Objects were
asked about the disease, taking history and risk factors for CAD
Time: from 3/2016 to 10/2018
Place: 108 Military Central Hospital
Research steps
- Step 1: Made a medical record (Appendix I)
- Step 2: Explained and requested to patients to participate in the study Collected information on history, examined for symptoms
- Step 3: Laboratory tests: blood test, electrocardiogram, echocardiogram
- Step 4: Recording 24-hour Holter ECG, recording SAECG
- Step 5: Collecting and processing research data
Signal averaged electrocardiogram recording procedure
- Preparing the SAECG
- Attaching electrodes on the skin:
according to the specified positions
- Measuring late potential parameters
on SAECG:
+ HFQRS: (ms)
+ LAHF: (ms)
+ RMS40: (µV)
+ Noise: Required less than 1µV, if above 1µV would be removed
Diagram of parameters of late potential
Trang 85 E (brown): Intercostal space 5, mid5 thoracic (near the nasopharynx)
- A (black): Same level as E in the left midaxillary line
- S (red): The apex (hilt) of the sternum
- I (white): Same level as E and A, right mid-axillary line
- Ground (green): in the middle of the
sternum or any other convenient location
- Attaching the electrode and connecting
the 24-hour Holter recorder
- Setting program for Holter system
- Unplug the device after 24 hours
Analysing 24 - hour Holter ECG result
Analyzing parameters: mean heart rate, fastest, slowest heart rate, ventricular and supraventricular arrhythmias, number of extrasystoles, features
of ventricular arrhythmias according to Lown's classification
CHAPTER 3: RESULTS OF THE STUDY 3.1 General features of study objects
3.1.1 Features of age, gender
The number of patients with chronic IHD was more common in the 61-75 age group (79.4% women and 64.1% men in this age group) Rarely in women under 60 years of age, and no young women < 45 years with chronic IHD Meanwhile, the number of male patients under 45 years old with chronic IHD accounted for 2.3%
Location of electrodes
Trang 9Table 3.1 Comparison of age and gender of the study objects
Parameters Patients group
(n = 162)
Control group
Age (year) 66,91 ± 8,92 64,15 ± 7,82 > 0,05* Gender Male 128 (79%) 60 (69%) > 0,05**
(*: t-test, **: χ2 -test)
3.2 Clinical, subclinical and late potential features in study objects
3.2.1 Clinical features
Heart rate, blood pressure of study objects
Table 3.3 Heart rate, blood pressure of study objects
Parameters Patients group
(n = 162)
Control group
Heart rate (bpm) 78,25 ± 8,66 76,47 ± 7,14 > 0,05 Systolic BP (mmHg) 125,74 ± 10,91 119,60 ± 6,30 < 0,05
Table 3.4 Features of heart failure of chronic IHD patients
80
09 00
Trang 10 Other symptoms
Table 3.5 Other clinical manifestations in patients with chronic IHD
Percentages in total of patient (n=162)
Trang 113.2.2.5 Features of 24-hour Holter ECG results
Table 3.13 24-hour Holter ECG results in 2 groups
Parameters Patient group
Control group (n = 87)
arrhythmias/
complicated VPCs
Grade 3 4 (2,5%) 0 (0%)
- Grade 4 (a, b) 42 (25,9%) 0 (0%)
Grade 5 9 (5,6%) 0 (0%)
(χ2- test)
3.2.3 Ventricular late potential features
3.2.3.1 Ventricular late potential features of chronic IHD and control group
Table 3.15 Results of late potential parameters
Parameters Patient group
(t – test)
Table 3.16 Late potential classification in patient and control groups
Classification Patient group
Trang 123.2.3.2 Late potential features in patients with chronic IHD
Table 3.17a Parameters of abnormal late potential and normal late potential
Các thông
số
Nhóm ĐTM bất thường (n = 62)
Nhóm ĐTM bình thường (n = 100) p
HFQRS (ms) 111,71 ± 17,39 82,30 ± 11,51 < 0,001
LAHF (ms) 41,11 ± 6,54 28,87 ± 9,39 < 0,001
RMS40 (µV) 16,84 ± 3,91 29,86 ± 12,75 < 0,001
(t – test)
The incidence of abnormal LP in different age groups
Table 3.18 Compared incidence of abnormal LP in age groups
Age groups Normal LP
Late potential features related with gender
Table 3.19 Compared incidence of abnormal LP in 2 subgroups
Late potential features in chronic IHD patients with smoking
Table 3.22 Late potential features related with smoking
Trang 13 Late potential features in chronic IHD patients with alcohol abuse
Table 3.23 Late potential features related with alcohol abuse
Parameters Alcohol abuse
Late potential features in chronic IHD patients with reduced EF
Table 3.28 LP features in group with EF < 40% and group with EF ≥ 40%
3.3.1 The relationship between late potential with some clinical features
3.3.1.2 Risk of abnormal LP associated with some clinical features and risk factors in patients with chronic IHD
Table 3.30 Risk of abnormal LP associated with clinical features
Clinical features
Normal LP (n=100)
Trang 143.3.2 The relationship between late potential with some subclinical features
3.3.2.1 The relationship between late potential with ECG features
Tabel 3.32 The relationship between ischemic location on ECG and late
Front wall
Back wall
Lateral wall
Multi region
Normal
(n, %)
67 (72,8%)
7 (41,2%)
9 (56,3%)
6 (60%)
11 (40,7%) Abnormal
(n, %)
25 (27,2%)
10 (58,8%)
7 (43,7%)
4 (40%)
16 (59,3%)
Abnormal LP (n = 62) OR 95%
3.3.2.4 Risk of abnormal LP associated with wall dyskinesia
Table 3.35 Risk of abnormal LP in patients with wall dyskinesia
Features
Normal LP (n = 100)
Abnormal LP (n = 62) OR 95%CI p
Trang 153.3.3 Relationship between late potential and ventricular arrhythmias (VA) in patients with chronic IHD
3.3.3.2 Evaluation of the risk of VA in patients with abnormal LP
Risk of couplet ventricular premature complexes (VPCs)
Table 3.37 Risk of couplet VPCs in chronic IHD
Parameters
Without couplet VPCs (n = 108)
With couplet VPCs (n=54)
HFQRS Normal 97 89,8 26 48,1 9,50
4,18-21,58 < 0,001 Abnormal 11 10,2 28 51,9
LAHF Normal 89 82,4 10 18,5 20,61
8,84-48,06 < 0,001 Abnormal 19 17,6 44 81,5
RMS40 Normal 73 67,6 5 30,4 20,44
7,49-55,81 < 0,001 Abnormal 35 32,4 49 69,6
(χ2- test)
Risk of ventricular tachycardia in chronic IHD
Table 3.38 Risk of ventricular tachycardia in chronic IHD
Parameters
Without ventricular tachycardia (n = 127)
With ventricular tachycardia (n=35)
HFQRS Normal 106 83,5 17 48,6 5,35
2,37-12,03 < 0,001 Abnormal 21 16,5 18 51,4
LAHF Normal 95 74,8 4 11,4 23,01
7,54-70,21 < 0,001 Abnormal 32 15,2 31 88,6
RMS40 Normal 77 60,6 1 2,9 52,36
6,95-394,78 < 0,001 Abnormal 50 39,4 34 97,1
(χ2- test)